Atlas Trials

Bioequivalency Study of Ensartinib Capsules in Healthy Volunteers

Clinical trial NCT03536481 · COMPLETED

Trial details

NCT number
NCT03536481
Sponsor
Betta Pharmaceuticals Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lung Cancer
Start date
2018-06-11
Primary completion
2019-01-09
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.